Form 4: Avidity Biosciences Director Transfers Shares to Family and Charitable Trusts
SEC Form 4 Filing
Director Arthur A. Levin reports gifting shares of Avidity Biosciences stock to family and charitable remainder trusts.
Summary
- On September 6, 2024, Arthur A. Levin, a director of Avidity Biosciences, Inc., reported a transaction involving the company's common stock.
- Levin gifted 22,500 shares to a family trust and 22,500 shares to a charitable remainder trust.
- Following these transactions, Levin directly owns 14,830 shares and indirectly owns 131,372 shares through a family trust and 22,500 shares through a charitable remainder trust.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing related to stock transactions, indicating a neutral sentiment.
Industry Context
This filing is a routine disclosure of insider transactions and doesn't necessarily reflect a change in the company's outlook or performance.
Stakeholder Impact
- The stock transfer may have a minor impact on shareholders due to the change in ownership structure, but it is unlikely to be significant.
Key Dates
| Date | Description |
|---|---|
| 09/06/2024 | Date of stock transfer to family and charitable trusts |
| 09/10/2024 | Date of signature for the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.